Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Kramer

Showing results (841-850 of 1,488) with videos related to

Pageof 149
Sort By:
Diabetes, Obesity & Metabolism|December 5, 2015
Acute renal haemodynamic effects of glucagon-like peptide-1 receptor agonist exenatide in healthy overweight menM H A Muskiet, L Tonneijck, M M Smits, et al.
Diabetes, Obesity & Metabolism|May 2, 2022
Combination therapy with exenatide decreases the dapagliflozin-induced changes in brain responses to anticipation and consumption of palatable food in patients with type 2 diabetes: A randomized controlled trialCharlotte C van Ruiten, Dick J Veltman, Madelief Wijdeveld, et al.
The Journal of Hospital Infection|October 5, 2017
Nudging to improve hand hygieneM G Caris, H A Labuschagne, M Dekker, et al.
Anticancer Research|January 18, 2003
Oral mucosal carcinogenesis in SENCAR miceTae-Won Kim, Qianming Chen, Xiaodong Shen, et al.
Alzheimer Disease and Associated Disorders|December 20, 2007
Longitudinal tracking of FTLD: toward developing clinical trial methodologyDavid S Knopman, Bradley S Boeve, Richard J Caselli, et al.
Journal of Human Hypertension|October 8, 2004
A randomized trial on sodium reduction in two developing countriesT Forrester, A Adeyemo, S Soarres-Wynter, et al.
Brain : a Journal of Neurology|February 3, 2007
Profiles of neuropsychological impairment in autopsy-defined Alzheimer's disease and cerebrovascular diseaseBruce R Reed, Dan M Mungas, Joel H Kramer, et al.
Journal of the American Geriatrics Society|January 31, 2012
Coronary artery disease is associated with cognitive decline independent of changes on magnetic resonance imaging in cognitively normal elderly adultsLing Zheng, Wendy J Mack, Helena C Chui, et al.
Parkinsonism & Related Disorders|December 3, 2014
Sensitive measures of executive dysfunction in non-demented Parkinson's diseaseNicholas T Bott, Erica T Johnson, Norbert Schuff, et al.
Alzheimer Disease and Associated Disorders|May 17, 2019
Alzheimer Disease-associated Cortical Atrophy Does not Differ Between Chinese and WhitesJia Fan, Marian Tse, Jessie S Carr, et al.
Pageof 149

Showing results (841-850 of 1,488) with videos related to

Sort By:
Pageof 149
Diabetes, Obesity & Metabolism|December 5, 2015
Acute renal haemodynamic effects of glucagon-like peptide-1 receptor agonist exenatide in healthy overweight menM H A Muskiet, L Tonneijck, M M Smits, et al.
Diabetes, Obesity & Metabolism|May 2, 2022
Combination therapy with exenatide decreases the dapagliflozin-induced changes in brain responses to anticipation and consumption of palatable food in patients with type 2 diabetes: A randomized controlled trialCharlotte C van Ruiten, Dick J Veltman, Madelief Wijdeveld, et al.
The Journal of Hospital Infection|October 5, 2017
Nudging to improve hand hygieneM G Caris, H A Labuschagne, M Dekker, et al.
Anticancer Research|January 18, 2003
Oral mucosal carcinogenesis in SENCAR miceTae-Won Kim, Qianming Chen, Xiaodong Shen, et al.
Alzheimer Disease and Associated Disorders|December 20, 2007
Longitudinal tracking of FTLD: toward developing clinical trial methodologyDavid S Knopman, Bradley S Boeve, Richard J Caselli, et al.
Journal of Human Hypertension|October 8, 2004
A randomized trial on sodium reduction in two developing countriesT Forrester, A Adeyemo, S Soarres-Wynter, et al.
Brain : a Journal of Neurology|February 3, 2007
Profiles of neuropsychological impairment in autopsy-defined Alzheimer's disease and cerebrovascular diseaseBruce R Reed, Dan M Mungas, Joel H Kramer, et al.
Journal of the American Geriatrics Society|January 31, 2012
Coronary artery disease is associated with cognitive decline independent of changes on magnetic resonance imaging in cognitively normal elderly adultsLing Zheng, Wendy J Mack, Helena C Chui, et al.
Parkinsonism & Related Disorders|December 3, 2014
Sensitive measures of executive dysfunction in non-demented Parkinson's diseaseNicholas T Bott, Erica T Johnson, Norbert Schuff, et al.
Alzheimer Disease and Associated Disorders|May 17, 2019
Alzheimer Disease-associated Cortical Atrophy Does not Differ Between Chinese and WhitesJia Fan, Marian Tse, Jessie S Carr, et al.
Pageof 149